As the chemotherapy induced expression of HIF-1α, and downstream targets, increased the tumorsphere forming capacity of the basal breast cancer lines tested, it is conceivable that chemotherapy induced HIF-1α stabilization and a concomitant increase in the CSC population is a contributing factor to treatment resistance in vivo. This evidence concerns the gene HIF1A and breast cancer.